Hormonal

Print Friendly, PDF & Email

Relosyl 50 µg/ml solution for injection

Treatment of follicular ovarian cysts. Combined with artificial insemination, to optimise the time of ovulation. Induction and synchronisation of oestrus and ovulation.

1. Warning

The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.

*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..

Quick product information

Active ingredient(s)Route of administrationWaiting timePackaging

Gonadorelin

Intra-muscular route

Meat: 0 days. Milk: 0 hours.

1 glass vial of 6, 20, 50 or 100 ml.

Country Availability

Belgium, Czech Republic, Germany, Morocco, Netherlands, Poland, Slovakia, Spain.

If your country is not listed, please contact our export team.

Contactar

Active ingredient(s)

Gonadorelin (as gonadorelin acetate)…………………… 50 µg/ml

Indications

Treatment of follicular ovarian cysts.

Combined with artificial insemination, to optimise ovulation time. Induction and synchronisation of oestrus and ovulation.

Contra-indications

Do not use in animals with known hypersensitivity to gonadorelin or any excipient.

Special precautions

Ovarian cysts: For the treatment of ovarian cysts, the condition of ovarian follicular cysts should be diagnosed by rectal palpation revealing the presence of persisting follicular structures with a diameter of over 2.5 cm and should be confirmed by the use of plasma or milk progesterone assay.

The product should be administered at least 14 days after calving due to the absence of receptivity of the hypophysis before that time.

For induction and synchronisation of the oestrum and ovulation in Fixed Time Artificial Insemination protocols (FTAI), the veterinary medicinal product must be administered at least 35 days after parturition.

For induction and synchronisation of the oestrum and ovulation in Fixed Time Artificial Insemination protocols (FTAI), the veterinary medicinal product must be administered at least 35 days after parturition.

Responses to the treatment may vary between herds or between cows within herds. However, the percentage of cows that come into oestrus during a determined period is in general greater than in untreated cows and the subsequent luteal phase has a normal duration. For the protocol that only includes PGF2α recommended for cycling cows: To maximise conception rates of cows to be treated, regular cyclic ovarian activity must be determined and confirmed.

Optimal results will be obtained in healthy cycling cows.

Animals in poor health, whether from illness, inadequate nutrition, or other factors, may respond poorly to treatment.

Posology

Treatment of follicular ovarian cysts: 100-150 micrograms of gonadorelin (as acetate) per animal (i.e. 2-3 ml of the product per animal). If necessary, treatment can be repeated at 1-2 week intervals.

In association with artificial insemination to optimise time of ovulation, which improves the chances that the treated cow will become fertile: 100 micrograms of gonadorelin (as acetate) per animal (i.e. 2 ml of the product per animal). It must be administered at the same time as artificial insemination and/or 12 days after this.

Waiting time

Meat: 0 days.

Milk: 0 hours.

Packaging

1 glass vial of 6, 20, 50 or 100 ml.